Patent details

EP1591108 Title: Solution formulations of sirolimus and its analogs for CAD treatment

Basic Information

Publication number:
EP1591108
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP052520160
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Solution formulations of sirolimus and its analogs for CAD treatment
French Title of Invention:
Formulations en solution de sirolimus et ses analogues pour le traitement de la coronaropathie
German Title of Invention:
Formulierungen von Sirolimus und seine Analoge in Lösungsform zur Behandlung von koronaren Herzkrankheit
SPC Number:

Dates

Filing date:
31/03/2005
Grant date:
16/03/2016
EP Publication Date:
16/03/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/11/2005
EP B1 Publication Date:
16/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/03/2016
Expiration date:
31/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2005
 
 

Name:
Cordis Corporation
Address:
14201 N.W. 60th Avenue, Miami Lakes, Florida 33014, United States (US)

Inventor

1

Name:
Zhao Jonathon Z.
Address:
United States (US)

2

Name:
Falotico Robert
Address:
United States (US)

Priority

Priority Number:
813965
Priority Date:
31/03/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/08;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages